These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25168455)

  • 1. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aceruloplasminemia, an iron metabolic disorder.
    Miyajima H
    Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
    Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
    EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia.
    Kaneko K; Yoshida K; Arima K; Ohara S; Miyajima H; Kato T; Ohta M; Ikeda SI
    J Neuropathol Exp Neurol; 2002 Dec; 61(12):1069-77. PubMed ID: 12484569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and pathological basis of aceruloplasminemia.
    Kono S; Miyajima H
    Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceruloplasmin in neurodegenerative diseases.
    Texel SJ; Xu X; Harris ZL
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1277-81. PubMed ID: 19021540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.
    Kono S; Yoshida K; Tomosugi N; Terada T; Hamaya Y; Kanaoka S; Miyajima H
    Biochim Biophys Acta; 2010 Nov; 1802(11):968-75. PubMed ID: 20655381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness.
    Kaneko K; Hineno A; Yoshida K; Ohara S; Morita H; Ikeda S
    Hum Pathol; 2012 Mar; 43(3):451-6. PubMed ID: 21889188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia.
    Oide T; Yoshida K; Kaneko K; Ohta M; Arima K
    Neuropathol Appl Neurobiol; 2006 Apr; 32(2):170-6. PubMed ID: 16599945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and liver iron accumulation in aceruloplasminemia.
    Fujita K; Osaki Y; Harada M; Kono S; Miyajima H; Izumi Y; Kaji R
    Neurology; 2013 Dec; 81(24):2145-6. PubMed ID: 24323439
    [No Abstract]   [Full Text] [Related]  

  • 14. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
    Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox active iron accumulation in aceruloplasminemia.
    Gonzalez-Cuyar LF; Perry G; Miyajima H; Atwood CS; Riveros-Angel M; Lyons PF; Siedlak SL; Smith MA; Castellani RJ
    Neuropathology; 2008 Oct; 28(5):466-71. PubMed ID: 18282164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.
    Kenawi M; Rouger E; Island ML; Leroyer P; Robin F; Rémy S; Tesson L; Anegon I; Nay K; Derbré F; Brissot P; Ropert M; Cavey T; Loréal O
    FASEB J; 2019 Dec; 33(12):13492-13502. PubMed ID: 31560858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Harris ZL; Klomp LW; Gitlin JD
    Am J Clin Nutr; 1998 May; 67(5 Suppl):972S-977S. PubMed ID: 9587138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aceruloplasminemia: retinal histopathologic manifestations and iron-mediated melanosome degradation.
    Wolkow N; Song Y; Wu TD; Qian J; Guerquin-Kern JL; Dunaief JL
    Arch Ophthalmol; 2011 Nov; 129(11):1466-74. PubMed ID: 22084216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
    Parks NE; Vandorpe RA; Moeller JJ
    Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
    Wang B; Wang XP
    Curr Neuropharmacol; 2019; 17(6):539-549. PubMed ID: 29737252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.